Memantine increases brain production of kynurenic acid via protein kinase A-dependent mechanism

Neuroscience Letters

Volumn 435, Issue 2, 2008, Pages 169-173

  Kloc, Renata ^a   Luchowska, Elzbieta ^a   Wielosz, Marian ^a   Owe Larsson, Bjorn ^b   Urbanska, Ewa M ^a,c  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Glial culture; In vitro; Kynurenic acid; Memantine

Indexed keywords

BUNGAROTOXIN RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; KT 5720; KYNURENIC ACID; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID; PROPRANOLOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BRAIN; BRAIN CORTEX; BRAIN SLICE; CELL CULTURE; CONTROLLED STUDY; DRUG MECHANISM; EX VIVO STUDY; GLIA CELL; IN VITRO STUDY; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BRAIN; CARBAZOLES; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; ISOQUINOLINES; KYNURENIC ACID; MALE; MEMANTINE; NEURONS; PIPERIDINES; PYRROLES; RATS; RATS, WISTAR;

EID: 41149172135     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.02.027     Document Type: Article

References (33)

1. Alberati-Giani D., Ricciardi-Castagnoli P., Kohler C., and Cesura A.M. Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells. J. Neurochem. 66 (1996) 996-1004
2. Ambrozi L., and Danielczyk W. Treatment of impaired cerebral function in psychogeriatric patients with memantine-results of a phase II double-blind study. Pharmacopsychiatry 21 (1988) 144-146
3. Caumont A.S., Octave J.N., and Hermans E. Amantadine and memantine induce the expression of the glial cell line-derived neurotrophic factor in C6 glioma cells. Neurosci. Lett. 394 (2006) 196-201
4. D'Andrea M.R., and Nagele R.G. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons. Curr. Pharm. Des. 12 (2006) 677-684
5. Danysz W., and Parsons C.G. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence. Int. J. Geriatr. Psychiatry 18 (2003) S23-S32
6. Giulian D., and Baker T.J. Characterization of amoeboid microglia isolated from developing mammalian brain. J. Neurosci. 6 (1986) 2163-2178
7. Hansen R.A., Gartlehner G., Lohr K.N., and Kaufer D.I. Functional outcomes of drug treatment in Alzheimer's disease: a systematic review and meta-analysis. Drugs Aging 24 (2007) 155-167
8. Hertz L., Chen Y., Gibbs M.E., Zang P., and Peng L. Astrocytic adrenoceptors: a major drug target in neurological and psychiatric disorders?. Curr. Drug Targets CNS Neurol. Disord. 3 (2004) 239-267
9. Hilmas C., Pereira E.F., Alkondon M., Rassoulpour A., Schwarcz R., and Albuquerque E.X. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J. Neurosci. 21 (2001) 7463-7473
10. 2+ in human neurons and astrocytes. Neuroscience 91 (1999) 1369-1378
11. Honegger U.E., Quack G., and Wiesmann U.N. Evidence for lysosomotropism of memantine in cultured human cells: cellular kinetics and effects of memantine on phospholipid content and composition, membrane fluidity and beta-adrenergic transmission. Pharmacol. Toxicol. 73 (1993) 202-208
12. Janiec W., Piekarska T., Paletko Z., and Pytlik M. The effect of drugs stimulating central dopaminergic system on transformation of exogenous adenine into c-AMP. Pol. J. Pharmacol. Pharm. 30 (1978) 529-535
13. Janiec W., Piekarska T., Szczypior M., and Misterkiewicz E. The effect of apomorphine, amantadine and dimethylaminoadamantane on the level of cyclic AMP in the rat striatum. Pol. J. Pharmacol. Pharm. 29 (1977) 93-99
14. Johnson J.W., and Kotermanski S.E. Mechanism of action of memantine. Curr. Opin. Pharmacol. 6 (2006) 61-67
15. Knyihar-Csillik E., Chadaide Z., Mihaly A., Krisztin-Peva B., Fenyo R., and Vecsei L. Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra. Acta Neuropathol. (Berl.) 112 (2006) 127-137
16. Kocki T., Luchowski P., Luchowska E., Wielosz M., Turski W.A., and Urbańska E.M. l-Cysteine sulphinate, endogenous sulphur-containing amino acid, inhibits rat brain kynurenic acid production via selective interference with kynurenine aminotransferase II. Neurosci. Lett. 346 (2003) 97-100
17. Kocki T., Wielosz M., Turski W.A., and Urbanska E.M. Enhancement of brain kynurenic acid production by anticonvulsants-novel mechanism of antiepileptic activity?. Eur. J. Pharmacol. 41 (2006) 147-151
18. Luchowska E., Luchowski P., Paczek R., Ziembowicz A., Kocki T., Turski W.A., Wielosz M., Łazarewicz J., and Urbanska E.M. Dual effect of dl-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid. J. Neurosci. Res. 79 (2005) 375-382
19. Luchowski P., Luchowska E., Turski W.A., and Urbanska E.M. 1-Methyl-4-phenylpyridinium and 3-nitropropionic acid diminish cortical synthesis of kynurenic acid via interference with kynurenine aminotransferases in rats. Neurosci. Lett. 330 (2002) 49-52
20. Martin-Ruiz C.M., Court J.A., Molnar E., Lee M., Gotti C., Mamalaki A., Tsouloufis T., Tzartos S., Ballard C., Perry R.H., and Perry E.K. Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. J. Neurochem. 73 (1999) 1635-1640
21. Maskell P.D., Speder P., Newberry N.R., and Bermudez I. Inhibition of human alpha 7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-d-aspartate receptors. Br. J. Pharmacol. 140 (2003) 1313-1319
22. Németh H., Toldi J., and Vécsei L. Role of kynurenines in the central and peripheral nervous systems. Curr. Neurovasc. Res. 2 (2005) 249-260
23. Parsons C.G., Danysz W., and Quack G. Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist-a review of preclinical data. Neuropharmacology 38 (1999) 735-767
24. Peeters M., Maloteaux J.M., and Hermans E. Distinct effects of amantadine and memantine on dopaminergic transmission in the rat striatum. Neurosci. Lett. 343 (2003) 205-209
25. Shearman E., Rossi S., Szasz B., Juranyi Z., Fallon S., Pomara N., Sershen H., and Lajtha A. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study. Brain Res. Bull. 69 (2006) 204-213
26. Storvik M., Linden A.M., Kontkanen O., Lakso M., Castren E., and Wong G. Induction of cAMP response element modulator (CREM) and inducible cAMP early repressor (ICER) expression in rat brain by uncompetitive N-methyl-d-aspartate receptor antagonists. J. Pharmacol. Exp. Ther. 294 (2000) 52-60
27. Teaktong T., Graham A., Court J., Perry R., Jaros E., Johnson M., Hall R., and Perry E. Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes. Glia 41 (2003) 207-211
28. Urbanska E., Dziki M., Czuczwar S.J., Kleinrok Z., and Turski W.A. Antiparkinsonian drugs memantine and trihexyphenidyl potentiate the anticonvulsant activity of valproate against maximal electroshock-induced seizures. Neuropharmacology 31 (1992) 1021-1026
29. Urbanska E.M., Kocki T., Saran T., Kleinrok Z., and Turski W.A. Impairment of brain kynurenic acid production by glutamate metabotropic receptor agonists. Neuroreport 8 (1997) 3501-3505
30. Vincent V.A.M., Van Dam A.-M., Persoons J.H.A., Schotanus K., Steinbusch H.W.N., Schoffelmeer A.N.M., and Berkenbosch F. Gradual inhibition of inducible nitric oxide synthase but not interleukin-1b production in rat microglial cells of endotoxin-treated mixed glial cell cultures. Glia 17 (1996) 94-102
31. Volbracht C., van Beek J., Zhu C., Blomgren K., and Leist M. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity. Eur. J. Neurosci. 23 (2006) 2611-2622
32. Xiu J., Nordberg A., Zhang J.-T., and Guan Z.-Z. Expression of nicotinic receptors on primary cultures of rat astrocytes and up-regulation of the α7, α4 and β2 subunits in response to nanomolar concentrations of the β-amyloid peptide. Neurochem. Int. 47 (2005) 281-290
33. Yu W.F., Guan Z.Z., Bogdanovic N., and Nordberg A. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritis plaques. Exp. Neurol. 192 (2005) 215-225